2024 surveillance of motor neurone disease: assessment and management (NICE guideline NG42)

Prioritisation Board agreed there was insufficient evidence in this area to update the guideline currently. It was agreed it will be reconsidered by Prioritisation Board in the 2026/27 business year.

Review decision: Not prioritised


This page was last updated: